The role of T-type calcium channels in epilepsy and pain

Current Pharmaceutical Design

Volumn 12, Issue 18, 2006, Pages 2189-2197

  Nelson, M T ^a,b   Todorovic, S M ^a,b   Perez Reyes, E ^a,b  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Absence; Calcium channels; Child; Cloning; Electrophysiology; Epilepsy; Genetics; Human; Ion channel gating; Mutation; Neuropathic pain; Pharmacology; Physiopathology

Indexed keywords

3ALPHA HYDROXY 5ALPHA PREGNAN 20 ONE; 5,5' DITHIOBIS(2 NITROBENZOIC ACID); ALFAXALONE; ANALGESIC AGENT; ANESTHETIC AGENT; ANTICONVULSIVE AGENT; CALCIUM CHANNEL T TYPE; CALCIUM ION; CAPSAICIN; DITHIOTHREITOL; ETHOSUXIMIDE; ION CHANNEL; ISOFLURANE; METHYLPHENYLSUCCINIMIDE; MIBEFRADIL; MORPHINE; NEW DRUG; NITROUS OXIDE; PACLITAXEL; SODIUM ION; SUCCINIMIDE DERIVATIVE; TETRAMETHYLSUCCINIMIDE; UNCLASSIFIED DRUG; VINCRISTINE;

ABSENCE; ANALGESIC ACTIVITY; ANGINA PECTORIS; ARTICLE; BENIGN CHILDHOOD EPILEPSY; CALCIUM TRANSPORT; CELL MEMBRANE DEPOLARIZATION; CHRONIC PAIN; CLINICAL TRIAL; DENDRITE; DRUG SCREENING; DRUG TARGETING; ENZYME ACTIVITY; ENZYME INHIBITION; EPILEPSY; GENE MUTATION; HUMAN; HYPERTENSION; MOLECULAR CLONING; MUTATIONAL ANALYSIS; NERVE CELL EXCITABILITY; NEUROMODULATION; NEUROPATHIC PAIN; NOCICEPTION; NOCICEPTIVE RECEPTOR; NONHUMAN; PAIN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RECEPTIVE FIELD; SENSORY NERVE CELL; SPIKE WAVE; SPINAL CORD DORSAL HORN; SYNAPTIC TRANSMISSION; THALAMOCORTICAL TRACT; THALAMUS; TRANSGENIC ANIMAL; UNSPECIFIED SIDE EFFECT; UPREGULATION; VISCERAL PAIN;

ANALGESICS; ANESTHETICS; ANIMALS; ANTICONVULSANTS; BRAIN; CALCIUM; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS, T-TYPE; EPILEPSY; HUMANS; MUTATION; NOCICEPTORS; PAIN; PAIN MEASUREMENT; PROTEIN CONFORMATION;

EID: 33745159996     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/138161206777585184     Document Type: Article

References (90)

1. Berridge MJ, Bootman MD, Lipp P. Calcium-a life and death signal. Nature 1998; 395: 645-8.
2. Ertel E, Campbell K, Harpold MM, Hofmann F, Mori Y, Perez-Reyes E, et al. Nomenclature of voltage-gated calcium channels. Neuron 2000; 25: 533-5.
3. Perez-Reyes E, Cribbs LL, Daud A, Lacerda AE, Barclay J, Williamson MP, et al. Molecular characterization of a neuronal low-voltage-activated T-type calcium channel. Nature 1998; 391: 896-900.
4. 2+ channel gene family. Circ Res 1998; 83: 103-9.
5. Lee JH, Daud AN, Cribbs LL, Lacerda AE, Pereverzev A, Klöckner U, et al. Cloning and expression of a novel member of the low voltage-activated T-type calcium channel family. J Neurosci 1999; 19: 1912-21.
6. Perez-Reyes E. Molecular physiology of low-voltage-activated T-type calcium channels. Physiol Rev 2003; 83: 117-61.
7. 1I) to neuronal excitability. J Physiol (Lond) 2002; 540: 3-14.
8. 2+ entry and frequency-dependence during mock action potentials. Eur J Neurosci 1999; 11: 4149-58.
9. 2+ current produces input signal amplification and bistability in cat and rat thalamocortical neurones. J Physiol (Lond) 1997; 505: 689-705.
10. Chemin J, Monteil A, Briquaire C, Richard S, Perez-Reyes E, Nargeot J, et al. Overexpression of T-type calcium channels in HEK-293 cells increases intracellular calcium without affecting cellular proliferation. FEBS Lett 2000; 478: 166-72.
11. Zhou Q, Godwin DW, O'Malley DM, Adams PR. Visualization of calcium influx through channels that shape the burst and tonic firing modes of thalamic relay cells. J Neurophysiol 1997; 77: 2816-25.
12. Munsch T, Budde T, Pape HC. Voltage-activated intracellular calcium transients in thalamic relay cells and interneurons. Neuroreport 1997; 8: 2411-8.
13. Llinás R, Yarom Y. Properties and distribution of ionic conductances generating electroresponsiveness of mammalian inferior olivary neurones in vitro. J Physiol (Lond) 1981; 315: 569-84.
14. Beurrier C, Congar P, Bioulac B, Hammond C. Subthalamic nucleus neurons switch from single-spike activity to burst-firing mode. J Neurosci 1999; 19: 599-609.
15. 2+ channels in hypoglossal motoneurons. J Neurosci 1994; 14: 5652-60.
16. 2+ signaling during terminal differentiation (fusion) of human myoblasts. Proc Natl Acad Sci USA 2000; 97: 7627-32.
17. Llinás RR. The intrinsic electrophysiological properties of mammalian neurons: insights into central nervous system function. Science 1988; 242: 1654-64.
18. Steriade M, Llinás RR. The functional states of the thalamus and the associated neuronal interplay. Physiol Rev 1988; 68: 649-742.
19. Gloor P, Fariello RG. Generalized epilepsy: some of its cellular mechanisms differ from those of focal epilesy. Trends Neurosci 1988; 11: 63-8.
20. Staba RJ, Wilson CL, Bragin A, Fried I, Engel J Jr. Sleep states differentiate single neuron activity recorded from human epileptic hippocampus, entorhinal cortex, and subiculum. J Neurosci 2002; 22: 5694-704.
21. Llinás R, Ribary U, Jeanmonod D, Cancro R, Kronberg E, Schulman J, et al. Thalamocortical dysrhythmia I. Functional and imaging aspects. Thalamus & Related Systems 2001; 1: 237-44.
22. Llinás RR, Ribary U, Jeanmonod D, Kronberg E, Mitra PP. Thalamocortical dysrhythmia: A neurological and neuropsychiatric syndrome characterized by magnetoencephalography. Proc Natl Acad Sci USA 1999; 96: 15222-7.
23. Jeanmonod D, Magnin M, Morel A. Low-threshold calcium spike bursts in the human thalamus. Common physiopathology for sensory, motor and limbic positive symptoms. Brain 1996; 119: 363-75.
24. Jeanmonod D, Magnin M, Morel A, Siegemund M, Cancro A, Lanz M, et al. Thalamocortical dysrhythmia II. Clinical and surgical aspects. Thalamus Relat Syst 2001; 1: 245-54.
25. Vergnes M, Marescaux C. In: Malafosse A, Genton P, Hirsch E, Marescaux C, Broglin D, Bernasconi R, eds., Idiopathic generalized epilepsies: clinical, experimental, and genetic aspects, John Libbey & Co.: London 1994; pp. 151-68.
26. Tsakiridou E, Bertollini L, de Curtis M, Avanzini G, Pape HC. Selective increase in T-type calcium conductance of reticular thalamic neurons in a rat model of absence epilepsy. J Neurosci 1995; 15: 3110-7.
27. Talley EM, Solórzano G, Depaulis A, Perez-Reyes E, Bayliss DA. Low-voltage-activated calcium channel subunit expression in a genetic model of absence epilepsy in the rat. Mol Brain Res 2000; 75: 159-65.
28. Zhang Y, Mori M, Burgess DL, Noebels JL. Mutations in high-voltage-activated calcium channel genes stimulate low-voltage-activated currents in mouse thalamic relay neurons. J Neurosci 2002; 22: 6362-71.
29. 2+ channels. Neuron 2001; 31: 35-45.
30. Faas GC, Vreugdenhil M, Wadman WJ. Calcium currents in pyramidal CA1 neurons in vitro after kindling epileptogenesis in the hippocampus of the rat. Neuroscience 1996; 75: 57-67.
31. 2+ channel causes a long-lasting modification of neuronal firing mode after status epilepticus. J Neurosci 2002; 22: 3645-55.
32. Lee JH, Gomora JC, Cribbs LL, Perez-Reyes E. Nickel block of three cloned T-type calcium channels: low concentrations selectively block α1H. Biophys J 1999; 77: 3034-42.
33. Niesen CE, Ge S. Chronic epilepsy in developing hippocampal neurons: electrophysiologic and morphologic features. Dev Neurosci 1999; 21: 328-38.
34. Chen Y, Lu J, Zhang Y, Pan H, Wu H, Xu K, et al. T-type calcium channel gene alpha (1G) is not associated with childhood absence epilepsy in the Chinese Han population. Neurosci Lett 2003; 341: 29-32.
35. v3.2 T-type calcium channel associated with Childhood Absence Epilepsy. J Biol Chem 2004; 279: 9681-4.
36. Perez-Reyes E, Chen Y, Arias JM, Vitko I, Wu X. In Annual Meeting of the Society for Neuroscience 2004.
37. Talley EM, Cribbs LL, Lee JH, Daud A, Perez-Reyes E, Bayliss DA. Differential distribution of three members of a gene family encoding low voltage-activated (T-type) calcium channels. J Neurosci 1999; 19: 1895-911.
38. Crunelli V, Leresche N. Childhood absence epilepsy: genes, channels, neurons and networks. Nat Rev Neurosci 2002; 3: 371-82.
39. Coulter DA, Huguenard JR, Prince DA. Characterization of ethosuximide reduction of low-threshold calcium current in thalamic neurons. Ann Neurol 1989; 25: 582-93.
40. Browne TR, Dreifuss FE, Dyken PR, Goode DJ, Penry JK, Porter RJ, et al. Ethosuximide in the treatment of absence (petit mal) seizures. Neurology 1975; 25: 515-24.
41. Coulter DA, Huguenard JR, Prince DA. Differential effects of petit mal anticonvulsants and convulsants on thalamic neurones: calcium current reduction. Br J Pharmacol 1990; 100: 800-6.
42. Leresche N, Parri HR, Erdemli G, Guyon A, Turner JP, Williams SR, et al. On the action of the anti-absence drug ethosuximide in the rat and cat thalamus. J Neurosci 1998; 18: 4842-53.
43. Gomora JC, Daud AN, Weiergräber M, Perez-Reyes E. Block of cloned human T-type calcium channels by succinimide antiepileptic drugs. Mol Pharmacol 2001; 60: 1121-32.
44. Bean BP, Cohen CJ, Tsien RW. Lidocaine block of cardiac sodium channels. J Gen Physiol 1983; 81: 613-42.
45. Narahashi T. Neuroreceptors and ion channels as the basis for drug action: past, present, and future. J Pharmacol Exp Ther 2000; 294: 1-26.
46. Huguenard JR, Prince DA. Intrathalamic rhythmicity studied in vitro: nominal T-current modulation causes robust antioscillatory effects. J Neurosci 1994; 14: 5485-502.
47. Raja SN, Meyer RA, Ringkamp M, Campbell, JN. In Textbook of Pain, Wall PD, Melzack R, eds.; Churchill Livingstone: Hong Kong 1999; pp. 11-58.
48. Devor M, Seltzer Z. In Textbook of Pain, Wall PD, Melzack R, eds.; Churchill Livingstone: Hong Kong 1999; pp. 129-64.
49. Caterina MJ, Julius D. The vanilloid receptor: a molecular gateway to the pain pathway. Annu Rev Neurosci 2001; 24: 487-517.
50. Millan MJ. The induction of pain: an integrative review. Prog Neurobiol 1999; 57: 1-164.
51. Harper AA, Lawson SN. Conduction velocity is related to morphological cell type in rat dorsal root ganglion neurones. J Physiol (Lond) 1985; 359: 31-46.
52. Harper AA, Lawson SN. Electrical properties of rat dorsal root ganglion neurones with different peripheral nerve conduction velocities. J Physiol (Lond) 1985; 359: 47-63.
53. Todorovic S, Anderson EG. Serotonin preferentially hyperpolarizes capsaicin-sensitive C type sensory neurons by activating 5-HT1A receptors. Brain Res 1992; 585: 212-8.
54. Schroeder JE, Fischbach PS, McCleskey EW. T-type calcium channels: heterogeneous expression in rat sensory neurons and selective modulation by phorbol esters. J Neurosci 1990; 10: 947-51.
55. Scroggs RS, Fox AP. Calcium current variation between acutely isolated adult rat dorsal root ganglion neurons of different size. J Physiol (Lond) 1992; 445: 639-58.
56. 2+ current in adult rat sensory neurons: effects of anticonvulsant and anesthetic agents. J Neurophysiol 1998; 79: 240-52.
57. Cardenas CG, Del Mar LP, Scroggs RS. Variation in serotonergic inhibition of calcium channel currents in four types of rat sensory neurons differentiated by membrane properties. J Neurophysiol 1995; 74: 1870-9.
58. Todorovic SM, Jevtovic-Todorovic V, Meyenburg A, Mennerick S, Perez-Reyes E, Romano C, et al. Redox modulation of T-type calcium channels in rat peripheral nociceptors. Neuron 2001; 31: 75-85.
59. Ikeda H, Heinke B, Ruscheweyh R, Sandkuhler J. Synaptic plasticity in spinal lamina I projection neurons that mediate hyperalgesia. Science 2003; 299: 1237-40.
60. Ryu PD, Randic M. Low- and high-voltage-activated calcium currents in rat spinal dorsal horn neurons. J Neurophysiol 1990; 63: 273-85.
61. Huang LY. Calcium channels in isolated rat dorsal horn neurones, including labelled spinothalamic and trigeminothalamic cells. J Physiol (Lond) 1989; 411: 161-77.
62. 2+ channel blocker, on dorsal horn neuronal responses in rats. Eur J Pharmacol 2001; 415: 141-9.
63. Mantyh PW, Rogers SD, Honore P, Allen BJ, Ghilardi JR, Li J, et al. Inhibition of hyperalgesia by ablation of lamina I spinal neurons expressing the substance P receptor. Science 1997; 278: 275-9.
64. Nichols ML, Allen BJ, Rogers SD, Ghilardi JR, Honore P, Luger NM, et al. Transmission of chronic nociception by spinal neurons expressing the substance P receptor. Science 1999; 286: 1558-61.
65. Lovinger DM, White G. Post-natal development of burst firing behavior and the low-threshold transient calcium current examined using freshly isolated neurons from rat dorsal root ganglia. Neurosci Lett 1989; 102: 50-7.
66. 2+ current triggers burst firing through an afterdepolarizing potential in an adult mammalian neuron. Proc Natl Acad Sci USA 1989; 86: 6802-6.
67. Study RE, Kral MG. Spontaneous action potential activity in isolated dorsal root ganglion neurons from rats with a painful neuropathy. Pain 1996; 65: 235-42.
68. v3.2 channel is a molecular substrate for inhibition of T-type calcium currents in rat sensory neurons by nitrous oxide. Mol Pharmacol 2001; 60: 603-10.
69. Todorovic SM, Perez-Reyes E, Lingle CJ. Anticonvulsants but not general anesthetics have differential blocking effects on different T-type current variants. Mol Pharmacol 2000; 58: 98-108.
70. Dogrul A, Yesilyurt O, Isimer A, Guzeldemir ME. L-type and T-type calcium channel blockade potentiate the analgesic effects of morphine and selective mu opioid agonist, but not to selective delta and kappa agonist at the level of the spinal cord in mice. Pain 2001; 93: 61-8.
71. Dogrul A, Zagli U, Tulunay FC. The role of T-type calcium channels in morphine analgesia, development of antinociceptive tolerance and dependence to morphine, and morphine abstinence syndrome. Life Sci 2002; 71: 725-34.
72. Osterrieder W, Holck M. In vitro pharmacologic profile of Ro 40-5967; a novel Ca2+ channel blocker with potent vasodilator but weak inotropic action. J Cardiovasc Pharmacol 1989; 13: 754-9.
73. Oparil S. Mibefradil, a T-channel-selective calcium antagonist: clinical trials in hypertension. Am J Hypertens 1998; 11: 88S-94S.
74. Clozel JP, Ertel EA, Ertel SI. Discovery and main pharmacological properties of mibefradil (Ro 40-5967), the first selective T-type calcium channel blocker. J Hypertens Suppl 1997; 15: S17-25.
75. 2+ channel currents in rat cerebellar granule neurons. J Neurosci 1995; 15: 2995-3012.
76. Yunker AM, McEnery MW. Low-voltage-activated ("T-type") calcium channels in review. J Bioenerg Biomembr 2003; 35: 533-75.
77. Bean BP, McDonough SI. Two for T. Neuron 1998; 20: 825-8.
78. + currents in human fusion-competent myoblasts. Br J Pharmacol 1999; 126: 245-50.
79. Dogrul A, Gardell L, Ossipov M, Tulunay F, Lai J, Porreca F. Reversal of experimental neuropathic pain by T-type calcium channel blockers. Pain 2003; 105: 159-68.
80. 2+ channels in vivo: alteration of nerve injury-induced thermal hyperalgesia. Pain 2004; 109: 328-39.
81. Flatters SJ, Bennett GJ. Ethosuximide reverses paclitaxel- and vincristine-induced painful peripheral neuropathy. Pain 2004; 109: 150-61.
82. 2+ current in adult rat sensory neurons by a steroid that lacks gammaaminobutyric acid-modulatory activity. Mol Pharmacol 1998; 54: 918-27.
83. 2+ channels in rat sensory neurons in vitro and potent peripheral analgesics in vivo. Mol Pharmacol 2004; mol.104.002402.
84. 2+ channels. Science 2003; 302: 117-9.
85. 2+ channel gene CACNA1H and childhood absence epilepsy. Ann Neurol 2003; 54: 239-43.
86. Hines ML, Carnevale NT. NEURON: a tool for neuroscientists. Neuroscientist 2001; 7: 123-35.
87. Destexhe A, Contreras D, Steriade M, Sejnowski TJ, Huguenard JR. In vivo, in vitro, and computational analysis of dendritic calcium currents in thalamic reticular neurons. J Neurosci 1996; 16: 169-85.
88. Armijo JA, Shushtarian M, Valdizan EM, Cuadrado A, de las Cuevas I, Adin J. Ion channels and epilepsy. Curr Pharm Des 2005; 11(15): 1975-2003.
89. Doering CJ, Zamponi GW. Molecular pharmacology of non-L-type calcium channels. Curr Pharm Des 2005; 11(15): 1887-98.
90. Gomtsyan A, Lee CH. Nonnucleoside inhibitors of adenosine kinase. Curr Pharm Des 2004; 10(10): 1093-103.